Skip to content

Study for the key technique of integrative therapy of Novel Coronavirus Pneumonia (COVID-19): the TCM symptoms and treatment regulation

Key techniques of combination therapy of Novel Coronavirus Pneumonia (COVID-19) - Study on TCM symptoms and treatment law

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2000003076
Enrollment
Unknown
Registered
2020-03-02
Start date
2020-02-28
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Sponsors

Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Criteria for inclusion of confirmed patients: (1) Comply with the diagnostic criteria of "Pneumonitis Diagnosis and Treatment Scheme for Novel Coronavirus Pneumonia (COVID-19) (Trial Version 5)"; (2) Above 2 years old; 2. Inclusion criteria for close contacts: One of the following contact situations after the onset of the case, but did not take effective protection: (1) People who live, study, work or have close contact with the case, such as working close to the case or sharing the same classroom or living in the same house as the case; (2) Medical staff, family members, or other people who have close contact with the case, such as direct treatment and care of the case, visiting or staying in the closed environment where the case is located, and the case is the same as other cases in the ward. Patients and their caregivers; (3) People who are in the same transportation as the case and have close contact with them, including those who have taken care of the patient on the transportation, and the patient's colleagues (family, colleagues, friends, etc.) are found to be likely to be near Distance from other passengers and flight attendants who are in contact with the patient; (4) On-site investigators evaluate that they are qualified to meet other contacts with close contacts.

Exclusion criteria

Exclusion criteria: (1) Patients during pregnancy; (2) Complicated liver, kidney, and metabolic diseases; (3) Have other serious primary cardiovascular disease, kidney disease, liver disease, hematological changes, or serious diseases that affect its quality of life, such as malignant tumors, AIDS, etc.; (4) Have or suspect a history of alcohol, drug abuse, etc.; (5) People with mental illness or manic disorder, or unwilling to accept research measures, or unwilling to cooperate with others; (6) Those who have participated in other clinical studies and influenced the results of this survey.

Design outcomes

Primary

MeasureTime frame
disease incidence;Duration of PCR normalization;Distribution pattern of TCM syndromes;

Secondary

MeasureTime frame
Chest imaging;incidence of complication;quality of life;Hospitalization time;Clinical symptom score;

Countries

China

Contacts

Public ContactZhang Wei

Affiliated Hospital of Shandong University of Traditional Chinese Medicine

zhagnweijinan@126.com+86 13505319899

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026